Skip to content

Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company.   Learn more → 

AdminNov 8, 2017< 1 min read

Big data essential in making decisions on medical treatments

Korea aims to leverage its extensive healthcare data to advance its medical industry, but progress has been limited thus far. Jeremy Rassen, Chief Scientific Officer of Aetion, is an esteemed authority in utilizing medical big data to inform treatment decisions. Aetion has developed a reliable system that analyzes real-world data from clinical and financial interactions in the U.S. healthcare sector, providing prompt, precise, and transparent real-world evidence (RWE).

Read More

RELATED ARTICLES